1. The oncolytic herpes simplex virus vector, G47Δ, effectively targets tamoxifen-resistant breast cancer cells
   JINGJING FAN et al, 2016, Oncology Reports CrossRef
2. Oncolytic bovine herpesvirus type 1 as a broad spectrum cancer therapeutic
   Breanne P Cuddington et al, 2015, Current Opinion in Virology CrossRef
3. Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer
   Ilkka Liikanen et al, 2016, Molecular Cancer Therapeutics CrossRef
4. The prevalence of varicella zoster virus, herpes simplex virus type 2, and human papillomavirus in breast cancerous tissues and their adjacent ones in Iran
   Ebrahim Faghihloo et al, 2023, Journal of Research in Medical Sciences CrossRef
5. Designer nanocarriers for navigating the systemic delivery of oncolytic viruses
   Faith Howard et al, 2020, Nanomedicine CrossRef
6. Recent advances of oncolytic virus in cancer therapy
   Moumita Mondal et al, 2020, Human Vaccines & Immunotherapeutics CrossRef
7. Redirecting oncolytic viruses: Engineering opportunists to take control of the tumour microenvironment
   Taylor R. Jamieson et al, 2020, Cytokine & Growth Factor Reviews CrossRef
8. Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors
   Chang-Myung Oh et al, 2020, International Journal of Molecular Sciences CrossRef
9. Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells
   Maria Eugenia Davola et al, 2023, Cancers CrossRef
10. Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?
    Maria Eugenia Davola et al, 2019, OncoImmunology CrossRef
11. Oncolytic viruses: A novel treatment strategy for breast cancer
    Mohammad Javanbakht et al, 2023, Genes & Diseases CrossRef
12. HSV-1 Oncolytic Viruses from Bench to Bedside: An Overview of Current Clinical Trials
    Marilin Koch et al, 2020, Cancers CrossRef
13. Treatment of Human Thyroid Carcinoma Cells with the G47delta Oncolytic Herpes Simplex Virus
    Jia-Ni Wang et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
14. Comparative proteomics as a tool for identifying specific alterations within interferon response pathways in human glioblastoma multiforme cells
    Irina A Tarasova et al, 2018, Oncotarget CrossRef
15. Triple‐mutated oncolytic herpes virus for treating both fast‐ and slow‐growing tumors
    Hiroshi Fukuhara et al, 2021, Cancer Science CrossRef
16. Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses
    Chad R. Irwin et al, 2017, Frontiers in Oncology CrossRef
17. Therapeutic potency of oncolytic virotherapy in breast cancer targeting, current status and perspective
    Safieh Ebrahimi et al, 2019, Journal of Cellular Biochemistry CrossRef
18. Inactivation of the UL37 Deamidase Enhances Virus Replication and Spread of the HSV-1(VC2) Oncolytic Vaccine Strain and Secretion of GM-CSF
    Carolyn M. Clark et al, 2023, Viruses CrossRef